USA - engelska - NLM (National Library of Medicine)

direct rx - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of cefuroxime axetil tablets usp and other antibacterial drugs, cefuroxime axetil tablets usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. note: cefuroxime axetil tablets usp and cefuroxime axetil for oral suspension are not bio­equivalent and are not substitutable on a milligram-per-milligram basis (see clinical pharmacology). cefuroxime axetil tablets usp: cefuroxime axetil tablets usp are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below:   - pharyngitis/tonsillitis cause

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - cefuroxime sodium 1.578 g equivalent to 1.5 g cefuroxime;  ;   - powder for injection - 1.5 g - active: cefuroxime sodium 1.578 g equivalent to 1.5 g cefuroxime     - cefuroxime is a bactericidal cephalosporin antibiotic which is resistant to most ?-lactamases and is active against a wide range of gram-positive and gram-negative organisms. it is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. susceptibility to cefuroxime sodium will vary with geography and time and local susceptibility data should be consulted where available. indications include - respiratory tract infections for example, acute exacerbation of chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections. - ear, nose and throat infections for example, sinusitis, tonsillitis, pharyngitis and otitis media. - urinary tract infections for example, acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. - soft-tissue infections for example, cellulitis, erysipelas and wound infections. - bone and joint infections for example, osteomyelitis and septic arthritis. - obstetric and gynaecological infections, pelvic inflammatory diseases. - gonorrhoea particularly when penicillin is unsuitable. - other infections including septicaemia, meningitis and peritonitis. - prophylaxis against infection in abdominal, pelvic, orthopaedic, cardiac, pulmonary, oesophageal and vascular surgery where there is increased risk from infection.

Taiwan - kinesiska - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

信東生技股份有限公司 桃園市桃園區介壽路２２號 (43211700) - cefuroxime (sodium);;cefuroxime (sodium);;cefuroxime (sodium);;cefuroxime (sodium) - 注射劑 - cefuroxime (sodium) (0812391110) (potency)mg; cefuroxime (sodium) (0812391110) (potency)mg; cefuroxime (sodium) (0812391110) (potency)mg; cefuroxime (sodium) (0812391110) (potency)mg - cefuroxime - 葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎球菌及其他具有感受性細菌引起之感染症

Taiwan - kinesiska - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

瑞士藥廠股份有限公司 台南市新市區中山路182號 (68770700) - cefuroxime (sodium);;cefuroxime (sodium);;cefuroxime (sodium);;cefuroxime (sodium) - 乾粉注射劑 - cefuroxime (sodium) (0812391110) (potency)mg; cefuroxime (sodium) (0812391110) (potency)mg; cefuroxime (sodium) (0812391110) (potency)mg; cefuroxime (sodium) (0812391110) (potency)mg - cefuroxime - 葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎球菌及其他具有感受性細菌引起之感染症

Kanada - engelska - Health Canada

fresenius kabi canada ltd - cefuroxime (cefuroxime sodium) - powder for solution - 750mg - cefuroxime (cefuroxime sodium) 750mg - second generation cephalosporins

Kanada - engelska - Health Canada

fresenius kabi canada ltd - cefuroxime (cefuroxime sodium) - powder for solution - 1.5g - cefuroxime (cefuroxime sodium) 1.5g - second generation cephalosporins

Kanada - engelska - Health Canada

fresenius kabi canada ltd - cefuroxime (cefuroxime sodium) - powder for solution - 7.5g - cefuroxime (cefuroxime sodium) 7.5g - second generation cephalosporins

Frankrike - franska - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

eugia pharma (malta) ltd - céfuroxime 50 mg sous forme de : céfuroxime sodique - poudre - pour un flacon > céfuroxime 50 mg sous forme de : céfuroxime sodique - organes sensoriels – médicaments ophtalmologiques – anti-infectieux – antibiotiques - classe pharmacothérapeutique organes sensoriels – médicaments ophtalmologiques – anti-infectieux – antibiotiques, - code atc : s01aa27cefuroxime arrow 50 mg, poudre pour solution injectable contient une substance active, la céfuroxime (sous forme de céfuroxime sodique) qui appartient au groupe d’antibiotiques appelé céphalosporines. les antibiotiques sont utilisés pour tuer les bactéries ou « germes » causant les infections.ce médicament sera utilisé si vous allez subir une intervention chirurgicale de l’œil pour cataracte (opacification du cristallin).votre chirurgien ophtalmologiste vous administrera ce médicament par injection dans l’œil à la fin de l’intervention chirurgicale de la cataracte, afin de prévenir une infection de l’œil

Irland - engelska - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - cefuroxime sodium - pdr for soln for injection - 250 base milligrams - second-generation cephalosporins

Irland - engelska - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - cefuroxime sodium - pdr for soln for injection - 750 base milligrams - second-generation cephalosporins